Cushing's syndrome in an infant secondary to malignant adrenocortical tumors with somatic mutation of beta-catenin

Pediatric and Developmental Pathology

Volumn 13, Issue 3, 2010, Pages 238-242

  Pusantisampan, Theerawut ^a   Sangkhathat, Surasak ^a   Kayasut, Kanita ^a   Kanngurn, Samornmas ^a   Jaruratanasirikul, Somchit ^a   Chotsampancharoen, Teerachit ^a   Kritsaneepaiboon, Supika ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Adrenocortical carcinoma; Beta catenin; Wnt signaling

Indexed keywords

BETA CATENIN; DEXAMETHASONE; HYDROCORTISONE; WNT PROTEIN; CTNNB1 PROTEIN, HUMAN;

ADRENAL CORTEX CARCINOMA; ADRENALECTOMY; ARTICLE; BIRTH WEIGHT; BLOOD PRESSURE; CANCER GRADING; CANCER SIZE; CANCER SURGERY; CARCINOGENESIS; CASE REPORT; CESAREAN SECTION; CODON; COMPUTER ASSISTED TOMOGRAPHY; CUSHING SYNDROME; DELETION MUTANT; DEXAMETHASONE SUPPRESSION TEST; DRUG MEGADOSE; EXON; FEMALE; FOLLOW UP; GENE DELETION; GENE SEQUENCE; HETEROZYGOSITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; INFANT; INFERIOR CAVA VEIN; KIDNEY CALCIFICATION; LIVER METASTASIS; LIVER NODULE; MITOSIS; MOON FACE; OBESITY; PLACENTA PREVIA; PREMATURE LABOR; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SOMATIC MUTATION; THAILAND; TUMOR NECROSIS; WEDGE RESECTION; WEIGHT GAIN; WILD TYPE; ADRENAL CORTEX TUMOR; GENETICS; LIVER RESECTION; LIVER TUMOR; METABOLISM; METASTASIS; PATHOLOGY; PREMATURITY; TREATMENT OUTCOME;

ADRENAL CORTEX NEOPLASMS; ADRENALECTOMY; ADRENOCORTICAL CARCINOMA; BETA CATENIN; CUSHING SYNDROME; FEMALE; GENE DELETION; HEPATECTOMY; HUMANS; INFANT; LIVER NEOPLASMS; PREMATURE BIRTH; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; WNT PROTEINS;

EID: 77956224859     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/09-07-0683-CR.1     Document Type: Article

References (14)

1. Lindholm J, Juul S, Jørgensen JO, et al. Incidence and late prognosis of Cushing's syndrome: a population-based study. J Clin Endocrinol Metab 2001;86:117-123. (Pubitemid 32111743)
2. Wagner J, Portwine C, Rabin K, et al. High frequency of germline p53 mutations in childhood adrenocortical cancer. J Natl Cancer Inst 1994;86:1707-1710. (Pubitemid 24354633)
3. Varley JM, McGown G, Thorncroft M, et al. Are there low-penetrance TP53 alleles? Evidence from childhood adrenocortical tumors. Am J Hum Genet 1999;65:995-1006. (Pubitemid 30462956)
4. Latronico AC, Pinto EM, Domenice S, et al. An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors. J Clin Endocrinol Metab 2001;86:4970-4973. (Pubitemid 33020551)
5. Koesters R, von Knebel Doeberitz M. The Wnt signaling pathway in solid childhood tumors. Cancer Lett 2003;198:123-138. (Pubitemid 37297785)
6. Tissier F, Cavard C, Groussin L, et al. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer Res 2005;65:7622-7627. (Pubitemid 41297234)
7. Tadjine M, Lampron A, Ouadi L, et al. Frequent mutations of beta-catenin gene in sporadic secreting adrenocortical adenomas. Clin Endocrinol (Oxf) 2008;68:264-270.
8. Tadjine M, Lampron A, Ouadi L, et al. Detection of somatic beta-catenin mutations in primary pigmented nodularadrenocortical disease (PPNAD). Clin Endocrinol (Oxf) 2008;69:367-373.
9. Aubert S, Wacrenier A, Leroy X, et al. Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors. Am J Surg Pathol 2002;26:1612-1619. (Pubitemid 35387224)
10. Linda NG, Libertino JM. Adrenocortical carcinoma: diagnosis, evaluation and treatment. J Urol 2003;169:5-11. (Pubitemid 35461537)
11. Ribelro RC, Michalkiewicz EL, Figuelredo BC, et al. Adrenocortical tumors in children. Braz J Med Biol Res 2000;33:1225-1234.
12. Cifti AO, Senocak ME, Tanyel C, et al. Adrenocortical tumors in children. J Pediatr Surg 2001;36:549-554. (Pubitemid 32268337)
13. Libé R, Bertherat J. Molecular genetics of adrenocortical tumors, from familial to sporadic diseases. Eur J Endocrinol 2005;153:477-487. (Pubitemid 41568145)
14. Gaujoux S, Tissier F, Groussin L, et al. Wnt/beta-catenin and 3′,5′-cyclic adenosine 5′-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors. J Clin Endocrinol Metab 2008;93:4135-4140.